NG
Natasha Giordano
Chief Executive OfficerDirector

Natasha Giordano insider trades: PLx Pharma (PLXP) stock buys and sales

Chief Executive Officer, PLx Pharma Last trade Mar 15, 2022 33 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2005
6
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Natasha reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 15, 2022PLXP↑ Buy$15K
Mar 4, 2015ACET↓ Sell$45K
Sep 9, 2014ACET↓ Sell$32K
Jun 6, 2014ACET↓ Sell$20K
Jun 2, 2014ACET↓ Sell$20K
May 23, 2014ACET↓ Sell$20K
May 21, 2014ACET↓ Sell$20K
Aug 12, 2005DRTE↓ Sell$229K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Natasha Giordano's insider trades

Natasha Giordano is Chief Executive Officer at PLx Pharma (PLXP). Since Aug 12, 2005, Natasha has reported 1 open-market purchase worth $15K and 7 sales worth $387K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (21 filings), shares withheld for taxes (2 filings), other transactions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PLXP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.